Please login to the form below

Not currently logged in
Email:
Password:

Cerenis appoints Dr John Paolini as chief medical officer

He will be responsible for the strategic planning and execution of the biopharmaceutical company's clinical trials

Dr John Paolini has joined biopharmaceutical company Cerenis as chief medical officer.

Dr Paolini comes to the Toulouse, France and Ann Arbor, US-based company with 15 years clinical and research experience, notably at Merck & Co and Bayer Healthcare Pharmaceuticals.

At Cerenis he will be responsible for the strategic planning and execution of the clinical trials for the company's portfolio of novel cardiovascular therapies, including lead product CER-001, which is currently being studied for acute coronary syndrome.

“The appointment of Dr Paolini comes at a crucial time in our development, with our lead drug candidate, CER-001 in phase II; this product addresses a significant unmet medical need and represents a multibillion dollar opportunity,” said Jean-Louis Dasseux, CEO of Cerenis.

29th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics